Elevated plasma levels of neuropeptide Y in female fibromyalgia patients

European Journal of Pain - Tập 3 - Trang 19-30 - 1999
Ulla Maria Anderberg1, Zhurong Liu2, Lars Berglund3, Fred Nyberg2
1Department of Neuroscience, Psychiatry, University Hospital, SE-751 85 Uppsala, Sweden
2Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
3Department of Public Health and Caring, Uppsala University, Sweden

Tóm tắt

Neuropeptide Y(NPY) co‐exists with norepinephrine in the sympathetic nervous system, and NPY may represent the sympathetic‐neuronal output. Fibromyalgia syndrome (FMS) patients have perturbations in the hypothalmic‐pituitary‐adrenal (HPA) axis and in the sympathetic stress axis as well. As opioid peptides, monoamines and sex steroids are integrated in the regulation of stress, it is interesting to further explore the role of NPY in FMS patients, as they show many symptoms that are related to perturbations of those systems.

In this study, plasma NPY levels were assessed in subgroups of FMS patients: cyclic (regular menstrual cycles), non‐cyclic (post‐menopausal), depressed and non‐depressed patients. In order to examine whether pain and other symptoms seen in FMS patients are correlated to the NPY levels, the patients were also registering 15 different symptoms daily during 28 days. Sex and age‐matched healthy controls were recruited for comparisons. Non‐parametric tests were used for the statistical analyses.

The results showed that the NPY levels were significantly elevated in the patients compared to the controls. In the luteal phase of the cyclic patients, the levels of the peptide were higher than in the corresponding controls. For the non‐cyclic patients, there was a positive correlation between physical symptoms and NPY levels, however, pain per se did not reach the significant level of correlation. The non‐depressed patients had the same levels of NPY as the depressed FMS patients, who also had a positive correlation between anxiety and NPY levels.

These results suggest that FMS patients have an altered activity in the NPY system, most likely due to prolonged and/or repeated stress, and that the hormonal state and time of the menstrual cycle also may be of importance in the complex pathophysiologic mechanism behind the development of FMS.


Tài liệu tham khảo

10.1002/art.1780271004 10.1002/art.1780400311 10.1300/J094v06n04_02 10.1300/J094v07n03_03 Anderburg U.M., 1999, Personality traits according to the Temperament and Character Inventory (TCI) in female fibromyalgia patients, Nordic J Psychiatry Bengtsson A., 1996, Causes of fibromyalgia are both peripheral and central, Lärtidnigen, 93, 161 10.1111/j.1476-5381.1991.tb09863.x 10.1210/jc.75.3.924 Chang C.L., 1992, Effect of premedication on changes of neuropeptide Y (NPY) in anesthesia, Ma Tsui Hsueh Tsa Chi, 30, 147 10.1001/archpsyc.1984.01790190025003 10.1001/jama.1992.03480090092034 Clauw D.J., 1995, Serum neuropeptides in patients with both fibromyalgia and chronic fatigue syndrome, J Musculosk Pain, 3 Conover W.J., 1980, Practical nonparametric statistics, 229 10.1300/J094v04n01_11 10.1002/art.1780371105 Dailey P.A., 1990, Psychological stress and the fibrositis/fibromyalgia syndrome, J Rheumatol, 17, 1380 10.1007/BF01845774 10.1300/J094v06n02_04 10.1016/0304-3959(92)90086-Q 10.1016/0021-9673(96)00211-7 10.1016/0167-0115(93)90378-L 10.1016/0002-9343(86)90879-X 10.1016/0002-9378(83)91086-4 10.1002/art.1780350612 Griep E.N., 1993, Altered reactivity of the hypothalamic‐pituitary‐adrenal axis in the primary fibromyalgia syndrome, J Rheumathol, 20, 469 10.1016/0024-3205(87)90465-6 10.1016/S0196-9781(97)00212-X Henriksson K.G., 1994, Pain and nociception in fibromyalgia: clinical and neurobiological considerations on aetiology and pathogenesis, Pain Rev, 1, 245 10.1016/0169-328X(94)90194-5 Hua X.Y., 1991, The antinociceptive effects of spinally administered neuropeptide Y in the rat, J Pharmacol Exp Ther, 258, 243 10.1016/0002-9343(92)90265-D 10.1096/fasebj.5.15.1743441 Katz R.S., 1996, Fibromyalgia, depression and alcoholism: a family history study, J Rheumatol, 23, 149 10.1111/j.1749-6632.1990.tb48941.x 10.3109/03009749109096808 10.1016/0304-3959(93)90060-3 Leu C.C., 1992, Personality characteristics of patients with fibromyalgia, Chung Hua I Hsueh Tsa Chih Taipei, 49, 264 Liu Z., 1995, Elevated substance P levels in cerebrospinal fluid from patients with fibromyalgia is contrasted by a decrease in Met‐Enkephalin‐Arg‐Phe, Analgesia, 1, 543, 10.3727/107156995819563997 10.1016/0304-3959(94)90167-8 10.1016/0022-3999(94)00093-K Mormede P., 1990, Involvement of neuropeptide Y in neuroendocrine stress responses, J Neural Transm Suppl, 29, 65 10.2165/00003495-199652030-00004 10.1016/0006-8993(91)90670-Q 10.1016/0024-3205(87)90251-7 10.1002/art.1780401103 Qiao Z.G., 1991, Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests, J Rheurnatol, 18, 1383 Russel I.J., 1989, Neurohormonal aspects of fibromyalgia syndrome, Rheum Dis Clin N Am, 15, 149, 10.1016/S0889-857X(21)00039-9 10.1300/J094v03n02_08 10.1146/annurev.me.27.020176.002133 10.1055/s-0028-1094472 10.1176/ajp.143.6.812-b 10.1016/S0079-6123(08)60652-4 Tukey J.W., 1977, Exploratory data analysis Vaeroy H., 1989, Altered sympthetic nervous system response in patients with fibromyalgia, J Rheumatol, 16, 1460 10.1016/0304-3959(91)90068-9 10.1111/j.1651-2227.1994.tb13135.x 10.1017/S0033291797006284 Knorring L., 1988, Proceedings of the Vth world congress on pain 10.3109/08039488809103219 10.1097/00006842-199711000-00003 10.1097/00006842-199711000-00002 10.1523/JNEUROSCI.08-07-02438.1988 10.1016/0163-7258(95)98598-K 10.4324/9780203414903 10.1002/art.1780330203 10.1001/archpsyc.1993.01820170073010 Young E.A., 1995, The role of gonadal steroids in hypothalamicpituitary‐adrenal axis regulation, Crit Rev Neurohiol, 9, 371 10.1002/art.1780340104 10.1111/j.1749-6632.1995.tb44683.x 10.1016/0002-9378(73)90207-X
Thông tin
Thông tin xuất bản

European Journal of Pain

Tập 3

19-30

Thông tin tác giả